RECENT NEWS
Roche to acquire Poseida Therapeutics
Roche has announced that it has entered into a definitive merger agreement to acquire Poseida Therapeutics, a public clinical-stage biopharmaceutical company pioneering donor-derived CAR-T cell therapies.
New anti-GFP antibodies from Jackson ImmunoResearch
Jackson ImmunoResearch, a manufacturer of secondary antibodies and immunoreagents for the life science market, has expanded its range of products for scientists seeking to harness the utility of the GFP (green fluorescent protein) tag.
Revvity expands work with Genomics England
Revvity has announced an expansion of its work with Genomics England that leverages both organisations' expertise and resources to advance critical genomic initiatives across the United Kingdom.
AMR: Glox Therapeutics awarded £1M PACE grant to develop new antibiotics
Glox Therapeutics has secured £1 million in grant funding from PACE (Pathways to Antimicrobial Clinical Efficacy), one of the UK’s largest public-private initiatives targeting early-stage antimicrobial medicines and diagnostic discovery.
Owkin and Proscia partner for CRC pre-screening
Biotech firm Owkin and AI-enabled pathology solutions company Proscia have announced a strategic partnership to streamline MSI testing for patients with colorectal cancer (CRC), the second most deadly cancer worldwide.
New nasal vaccine shows promise in curbing whooping cough spread
With whooping cough cases on the rise in many areas around the world, a new nasal vaccine developed by Tulane University may hold the key to reducing the spread of the highly contagious respiratory disease.
Biofidelity launches Aspyre Lung reagents
Genomics company Biofidelity has announced the launch of Aspyre Lung reagents for liquid biopsy samples. Aspyre Lung identifies established non-small cell lung cancer (NSCLC) biomarkers in both DNA and RNA from tissue and blood in a single straightforward, four-step workflow and runs on existing qPCR platforms, enabling simple integration into laboratories globally.
Linkam launches CMS196V4 stage for cryo-CLEM microscopy
Linkam Scientific Instruments has announced new updates to its specialist CMS196 cryo-stage. The CMS196V4 supports cryo-correlative light and electron microscopy (cryo-CLEM) and allows researchers to investigate samples at cryogenic temperatures down to < -195 °C.
Abbott opens state-of-the-art manufacturing facility in Kilkenny, Ireland
Abbott has marked the official opening of its state-of-the-art manufacturing facility in Kilkenny, Ireland with a ceremony attended by Taoiseach Simon Harris and Abbott Chairman and Chief Executive Officer Robert Ford. The site is a global manufacturing centre of excellence for Abbott's diabetes care business and will employ more than 800 people.
Lunit and AstraZeneca partner for AI-powered digital pathology cancer tools
Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has announced a strategic collaboration with AstraZeneca, a leading pharmaceutical company, to develop AI-powered digital pathology solutions for rapid and convenient prediction of non-small cell lung cancer driver mutations (NSCLC).
Mast Group chosen for Innovate UK's AMR project in Sweden
Mast Group has been selected for the Innovate UK Global Business Innovation Programme (GBIP) focused on Antimicrobial Resistance (AMR) in Sweden. The programme is designed to help UK businesses to grow and scale on a global stage through building R&D and innovation collaborations and partnerships.
New partnership to drive innovation in diagnostics and patient care
bioMérieux, a world leader in the field of in vitro diagnostics, has announced its first Data & IT Centre of Reference partnership with St James's Hospital, Ireland. This landmark collaboration was celebrated with a hybrid event held at the Davis Coakley Lecture Theatre, St James's Hospital, Dublin on 14 November, marking a historic milestone for bioMérieux.
Antibiotic resistant infections continue to rise
National surveillance data published by the UK Health Security Agency show that antibiotic-resistant infections in 2023 surpassed pre-pandemic levels. There were an estimated 66,730 serious antibiotic-resistant infections in 2023, compared to 62,314 in 2019.
MHRA opens consultation on pre-market regulations for medical devices
The Medicines and Healthcare products Regulatory Agency (MHRA) has launcjed a consultation on proposed changes to the regulatory requirements a medical device (including IVDs) must meet before it is placed on the market in Great Britain. The consultation will close on 5 January 2025.
Bio-Rad to celebrate oncology progress at AMP 2024
Bio-Rad Laboratories has announced updates on its oncology assay portfolio and regulatory milestones, ahead of its presence at the AMP 2024 meeting.
Northern Ireland’s laboratory services reach another IT milestone
Clinisys WinPath go-lives at Northern Health and Social Care Trust and the cervical cytology screening service complete phase three of the CoreLIMS programme to transform pathology services across the country.
NHS drones delivering blood samples for Guy's and St Thomas'
A medical drone delivery service for Guy's and St Thomas' NHS Foundation Trust, in partnership with Apian and Wing, is now up and running in London following its first successful flights. The six-month trial could become the blueprint for drone delivery of other medical items across the wider NHS.
Catch up with the latest issue of Pathology in Practice!
The October issue of PiP has been published and is available to read online.
New insight into GI goblet cells
In a recent study, researchers at the University of California, San Diego, have provided new insights into the central role of goblet cells - specialised cells that line the gut - in maintaining a healthy and balanced immune environment within the gastrointestinal (GI) tract. The findings open promising avenues for therapies that target goblet cell functions and could help develop treatments for GI diseases affecting millions globally.
Secretary of State pledges to contain NHS agency spend
The government and NHS England are set to reveal plans to reduce the NHS’s reliance on agency staff, as the cost to the health service of hiring temporary workers sits at £3 billion a year.
Latest Issues
UK NEQAS IMPROVES PATIENT CARE
We aim to improve patient care through monitoring the quality of tests and their reporting, in an independent manner and on a not-for-profit basis.
We are here to help ensure optimal quality in testing for the benefit of patients.
We believe that the result of tests should be:
BSMT 40th Anniversary Microbiology Conference
RAF Museum, Hendon, London NW9 5LL
15 May, 2025
Transforming Digital Pathology & AI: The Path Forward
Royal College Of Physicians Of Edinburgh
15 May, 2025
The 10 Year Plan - Clinical Innovations Expo
Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025
Incorrect Blood Component Transfused: a SHOT webinar
Online
21 May 2025
Near miss reporting and WBIT: a SHOT webinar
Online
9 June 2025